These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23739513)

  • 21. [Use of cerebrolysin in the treatment of prolonged extrapyramidal complications of neuroleptic therapy].
    Kontsevoĭ VA; Medvedev AV; Andrusenko MP; Zvenigorodskaia IuV; Sheshenin VS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):39-44. PubMed ID: 11517474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic results with Cerebrolysin in the treatment of dementia.
    Rainer M; Brunnbauer M; Dunky A; Ender F; Goldsteiner H; Holl O; Kotlan P; Paulitsch G; Reiner C; Stössl J; Zachhuber C; Mössler H
    Wien Med Wochenschr; 1997; 147(18):426-31. PubMed ID: 9408984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An effect of long-term cerebrolysin therapy in combination with neuroleptics on behavioral and cognitive disturbances in endogenous childhood autism].
    Radzivil MG; Bashina VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):21-5. PubMed ID: 16548370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and pathogenetical peculiarities and treatment policy in ischemic stroke of elderly and old age].
    Gafurov BG; Alikulova NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):44-6. PubMed ID: 15559220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of a randomized double-blind placebo-controlled trial of cerebrolysin].
    Vereshchagin NV; Suslina ZA; Timerbaeva SL; Kashina EM; Gnezditskiĭ VV; Maksimova MIu; Rebrova OIu; Smirnova IN
    Ter Arkh; 2001; 73(4):22-7. PubMed ID: 11494441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effects of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms.
    Xiao S; Xue H; Li G; Yuan C; Li X; Chen C; Wu HZ; Mitchell P; Zhang M
    Aust N Z J Psychiatry; 2012 Feb; 46(2):153-60. PubMed ID: 22311531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin.
    Alvarez XA; Cacabelos R; Sampedro C; Aleixandre M; Linares C; Granizo E; Doppler E; Moessler H
    Eur J Neurol; 2011 Jan; 18(1):59-68. PubMed ID: 20500802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asynchronous language acquisition in developmental dysphasia.
    Ouellet C; Cohen H; Le Normand MT; Braun C
    Brain Cogn; 2000; 43(1-3):352-7. PubMed ID: 10857724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy.
    Rüther E; Ritter R; Apecechea M; Freytag S; Gmeinbauer R; Windisch M
    J Neural Transm (Vienna); 2000; 107(7):815-29. PubMed ID: 11005546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A longitudinal study of children with developmental dysphasia.
    Dlouhá O
    Prague Med Rep; 2007; 108(4):324-32. PubMed ID: 18780644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ApoE genotype and efficacy of neurotrophic and cholinergic therapy in Alzheimer's disease].
    Gavrilova SI; Kolykhalov IV; Korovaĭtseva GI; Zharikov GA; Kalyn IaB; Selezneva ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(4):27-34. PubMed ID: 15880838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cerebrolysin in treatment of painful diabetic neuropathy].
    Biesenbach G; Grafinger P; Eichbauer-Sturm G; Zazgornik J
    Wien Med Wochenschr; 1997; 147(3):63-6. PubMed ID: 9173675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experience with using high doses of cerebrolysin in vascular dementia].
    Iakhno NN; Damulin IV; Zakharov VV; Levin OS; Elkin MN
    Ter Arkh; 1996; 68(10):65-9. PubMed ID: 9026950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influence of cerebrolysin on the efficiency of subsequent therapy with amiridine++ in Alzheimer's disease patients (neuropsychological investigation)].
    Roshchina IF; Kolykhalov IV; Selezneva ND; Zharikov GA; Gerasimov NP; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):43-6. PubMed ID: 10629930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacopuncture in combined treatment of children with neurosensory hypoacusis].
    Sukhareva MP; Aref'eva NA; Farkhutdinova LV
    Vestn Otorinolaringol; 2000; (6):24-6. PubMed ID: 11187070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Speech production and speech comprehension of dysgrammatic speech of preschool children].
    Veit SE; Castell R
    Z Kinder Jugendpsychiatr; 1992 Mar; 20(1):12-21. PubMed ID: 1585732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental dysphasia: clinical importance and underlying neurological causes.
    Njiokiktjien C
    Acta Paedopsychiatr; 1990; 53(2):126-37. PubMed ID: 1704678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health related quality of life in parents of children with speech and hearing impairment.
    Aras I; Stevanović R; Vlahović S; Stevanović S; Kolarić B; Kondić L
    Int J Pediatr Otorhinolaryngol; 2014 Feb; 78(2):323-9. PubMed ID: 24388315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of cerebrolysin intravenous injections in resistant forms of night enuresis in children].
    Gruzman AV; Levina IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(11):46. PubMed ID: 9845942
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin.
    Onose G; Mureşanu DF; Ciurea AV; Daia Chendreanu C; Mihaescu AS; Mardare DC; Andone I; Spânu A; Popescu C; Dumitrescu A; Popescu M; Grigorean V; Ungur B; Marinescu F; Colibbeanu I; Onose L; Haras M; Sandu A; Spircu T
    J Med Life; 2009; 2(4):350-60. PubMed ID: 20108748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.